Convalescent plasma for COVID-19 in oncohematological patients: a call for revision of the European Conference on Infections in Leukemia-9 (ECIL-9) guidelines

Daniele Focosi; Massimo Franchini; Jonathon W Senefeld; Arturo Casadevall; Michael J Joyner

doi:10.1016/j.jcvp.2022.100128

Convalescent plasma for COVID-19 in oncohematological patients: a call for revision of the European Conference on Infections in Leukemia-9 (ECIL-9) guidelines

J Clin Virol Plus. 2023 Feb;3(1):100128. doi: 10.1016/j.jcvp.2022.100128. Epub 2022 Dec 6.

Authors

Daniele Focosi¹, Massimo Franchini², Jonathon W Senefeld³, Arturo Casadevall⁴, Michael J Joyner³

Affiliations

¹ North-Western Tuscany Blood Bank, Pisa University Hospital, via Paradisa 2, Pisa 56124, Italy.
² Division of Transfusion Medicine, Carlo Poma Hospital, 46100 Mantua, Italy.
³ Department of Anesthesiology, Perioperative Medicine, Mayo Clinic, Rochester, MN 55902, United States.
⁴ Department of Medicine, Johns Hopkins School of Public Health and School of Medicine, Baltimore, MD 21218, United States.

No abstract available

Keywords: CCP, COVID-19 convalescent plasma; COVID19; Convalescent plasma; ECIL-9, European Conference on Infections in Leukemia; Immunosuppression; Monoclonal antibodies; SARS-CoV-2.